Lewis JD - Search Results

1

Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease.

Osterman MT, Sandborn WJ, Colombel JF, Robinson AM, Lau W, Huang B, Pollack PF, Thakkar RB, Lewis JD. Osterman MT, et al. Among authors: lewis jd. Gastroenterology. 2014 Apr;146(4):941-9. doi: 10.1053/j.gastro.2013.12.025. Epub 2013 Dec 18. Gastroenterology. 2014. PMID: 24361468

2

Cancer risk in patients with inflammatory bowel disease.

Lewis JD, Deren JJ, Lichtenstein GR. Lewis JD, et al. Gastroenterol Clin North Am. 1999 Jun;28(2):459-77, x. doi: 10.1016/s0889-8553(05)70065-0. Gastroenterol Clin North Am. 1999. PMID: 10372277 Free article. Review.

3

Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma.

Lewis JD, Schwartz JS, Lichtenstein GR. Lewis JD, et al. Gastroenterology. 2000 Jun;118(6):1018-24. doi: 10.1016/s0016-5085(00)70353-2. Gastroenterology. 2000. PMID: 10833475 Free article.

4

Inflammatory bowel disease is not associated with an increased risk of lymphoma.

Lewis JD, Bilker WB, Brensinger C, Deren JJ, Vaughn DJ, Strom BL. Lewis JD, et al. Gastroenterology. 2001 Nov;121(5):1080-7. doi: 10.1053/gast.2001.28703. Gastroenterology. 2001. PMID: 11677199

5

Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications.

Lewis JD, Bilker WB, Brensinger C, Farrar JT, Strom BL. Lewis JD, et al. Am J Gastroenterol. 2002 Oct;97(10):2540-9. doi: 10.1111/j.1572-0241.2002.06037.x. Am J Gastroenterol. 2002. PMID: 12385436

6

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.

Su C, Salzberg BA, Lewis JD, Deren JJ, Kornbluth A, Katzka DA, Stein RB, Adler DR, Lichtenstein GR. Su C, et al. Among authors: lewis jd. Am J Gastroenterol. 2002 Oct;97(10):2577-84. doi: 10.1111/j.1572-0241.2002.06026.x. Am J Gastroenterol. 2002. PMID: 12385442

7

Seasonal variation in flares of inflammatory bowel disease.

Lewis JD, Aberra FN, Lichtenstein GR, Bilker WB, Brensinger C, Strom BL. Lewis JD, et al. Gastroenterology. 2004 Mar;126(3):665-73. doi: 10.1053/j.gastro.2003.12.003. Gastroenterology. 2004. PMID: 14988820

8

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease.

Su C, Lichtenstein GR, Krok K, Brensinger CM, Lewis JD. Su C, et al. Among authors: lewis jd. Gastroenterology. 2004 May;126(5):1257-69. doi: 10.1053/j.gastro.2004.01.024. Gastroenterology. 2004. PMID: 15131785 Review.

9

Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients.

Yang YX, Hennessy S, Lewis JD. Yang YX, et al. Among authors: lewis jd. Gastroenterology. 2004 Oct;127(4):1044-50. doi: 10.1053/j.gastro.2004.07.011. Gastroenterology. 2004. PMID: 15480982

10

Malignancies in inflammatory bowel disease.

Srinivasan R, Lewis JD. Srinivasan R, et al. Among authors: lewis jd. Curr Opin Gastroenterol. 2003 Jul;19(4):366-70. doi: 10.1097/00001574-200307000-00007. Curr Opin Gastroenterol. 2003. PMID: 15703578

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,199 results

Search Page

Filters